Shanxi Indian Gleevec, Indian Gleevec purchasing agent, Indian Gleevec price 13621079267

Imatinib mesylate tablets'', the trade name of -r, is used to treat chronic myeloid leukemia and malignant gastrointestinal stromal tumors. The principle is to fuse genes so that the BR-B protein cannot obtain phosphorylation
[] '',-, cannot be activated, and cannot issue instructions, and the proliferation of cells is inhibited. < ../.
..b />
'',-r Common name: Imatinib mesylate (produced by an Indian company. Commonly known as: Indian Gleevec) Scientific name: English Name: b Specification: tablet/bottle
Gleevec'',-r (imatinib mesylate) is a new generation of inhibitory effect on platelet-derived growth factor (PLG) receptor protein kinase Targeted anticancer drugs. Gleevec is the most effective of all anti-tumor drugs. The effective rate of Gleevec in the treatment of newly diagnosed
chronic myelogenous leukemia'',-r () is more than %, and % of patients can obtain cytological remission.
'',-r Gleevec (
Imatinib mesylate'',-r) is packaged as tablets per bottle, each tablet contains. Imatinib mesylate, equivalent of imatinib free base. Medicines are packaged in white polyethylene bottles.
'',-r The results of the Phase III clinical trial show that Gleevec is more than 50% effective in the treatment of newly diagnosed chronic myelogenous leukemia (CML), and % of patients can achieve cytological remission. The effective rates during the early stage and acute change stage also reached % and % respectively. The effective rate of Gleevec against gastrointestinal stromal tumors is also as high as %.
'',-r Indications:
'',
'',-r Gleevec (imatinib mesylate) is used to treat newly diagnosed Philadelphia chromosome-positive ( +) in adults with chronic myelogenous leukemia in the chronic phase.
'',
'',-r Gleevec (imatinib mesylate) is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase and accelerated phase. Imatinib acid is also used to treat chronic myelogenous leukemia in the chronic phase that has been treated with interferon.
'',
'',-r Gleevec (imatinib mesylate) is also used to treat pediatric chronic myelogenous leukemia that has relapsed after myelosuppression or has failed to respond to interferon therapy.
'',-r Gastrointestinal stromal tumor ()
'',-r Gleevec (imatinib mesylate) is used to treat ()-positive inoperable or metastatic tumors malignant gastrointestinal stromal tumor!
'',-rMain toxic and side effects The most common toxic and side effects include: superficial
edema'',-r, malignancy and vomiting,
muscle soreness'',-r,< br/>Muscle cramps'',-r, rash and diarrhea.
'',-rHematologic toxicities, including neutropenia and thrombocytopenia, are common side effects of Gleevec (imatinib) treatment, but they occur less frequently in newly diagnosed CML patients< br/>